succinobucol has been researched along with Invasiveness, Neoplasm in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, H; Chen, L; Gu, W; He, X; Li, Y; Yin, Q; Yu, H; Zhang, Z; Zhao, S | 1 |
Cao, H; Dan, Z; He, X; Li, Y; Shen, Q; Xu, M; Xu, Y; Yin, Q; Yu, H; Zeng, L; Zhang, P; Zhang, Z; Zhong, D; Zou, L | 1 |
2 other study(ies) available for succinobucol and Invasiveness, Neoplasm
Article | Year |
---|---|
Hydrophobic interaction mediating self-assembled nanoparticles of succinobucol suppress lung metastasis of breast cancer by inhibition of VCAM-1 expression.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Biological Availability; Breast Neoplasms; Cell Movement; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Carriers; Female; Hydrophobic and Hydrophilic Interactions; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nanomedicine; Nanoparticles; Neoplasm Invasiveness; Particle Size; Poloxamer; Probucol; Rats, Sprague-Dawley; RAW 264.7 Cells; Signal Transduction; Technology, Pharmaceutical; Tissue Distribution; Vascular Cell Adhesion Molecule-1 | 2015 |
A pH-Responsive Host-guest Nanosystem Loading Succinobucol Suppresses Lung Metastasis of Breast Cancer.
Topics: Animals; Antineoplastic Agents; beta-Cyclodextrins; Breast Neoplasms; Cell Movement; Disease Models, Animal; Drug Delivery Systems; Female; Hydrogen-Ion Concentration; Lung Neoplasms; Mice, Inbred BALB C; Nanostructures; Neoplasm Invasiveness; Polyethylene Glycols; Probucol; Treatment Outcome | 2016 |